Epigenetic regulation of inducible gene expression in the immune system

Immunology

Volumn 139, Issue 3, 2013, Pages 285-293

  Lim, Pek Siew ^a   Li, Jasmine ^a,b   Holloway, Adele F ^c   Rao, Sudha ^a  

^a UNIVERSITY OF CANBERRA   (Australia)

^b Australian National University   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Genomics; T cells; Transcription factors gene regulation

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE H2A; HISTONE H2B; HISTONE H3; HISTONE H4; INTERLEUKIN 2; TRANSCRIPTION FACTOR CTCF;

ACETYLATION; ARTICLE; BIOINFORMATICS; BIOTINYLATION; CD4+ T LYMPHOCYTE; CELL DIVISION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN STRUCTURE; CPG ISLAND; DNA SEQUENCE; DNA TEMPLATE; EMBRYONIC STEM CELL; ENZYME ACTIVITY; EPIGENETICS; EUCHROMATIN; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HETEROCHROMATIN; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; IMMUNE SYSTEM; IMMUNOREGULATION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; SUMOYLATION; T LYMPHOCYTE ACTIVATION; UBIQUITINATION;

CHROMATIN; EPIGENOMICS; GENE EXPRESSION REGULATION; HUMANS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES; TRANSCRIPTION FACTORS;

EID: 84879216186     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12100     Document Type: Article

References (77)

1. Bird A. Perceptions of epigenetics. Nature 2007; 447:396-8.
2. Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ. Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature 1997; 389:251-60.
3. Reid G, Gallais R, Metivier R. Marking time: the dynamic role of chromatin and covalent modification in transcription. Int J Biochem Cell Biol 2009; 41:155-63.
4. Hager GL, McNally JG, Misteli T. Transcription dynamics. Mol Cell 2009; 35:741-53.
5. Kouzarides T. Chromatin modifications and their function. Cell 2007; 128:693-705.
6. Tan M, Luo H, Lee S et al. Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell 2011; 146:1016-28.
7. Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell 2012; 150:12-27.
8. Margueron R, Reinberg D. Chromatin structure and the inheritance of epigenetic information. Nat Rev Genet 2010; 11:285-96.
9. Bernstein BE, Mikkelsen TS, Xie X et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006; 125:315-26.
10. Yang XJ. Lysine acetylation and the bromodomain: a new partnership for signaling. BioEssays 2004; 26:1076-87.
11. Marmorstein R, Roth SY. Histone acetyltransferases: function, structure, and catalysis. Curr Opin Genet Dev 2001; 11:155-61.
12. de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 2003; 370:737-49.
13. Martin C, Zhang Y. The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol 2005; 6:838-49.
14. Klose RJ, Zhang Y. Regulation of histone methylation by demethylimination and demethylation. Nat Rev Mol Cell Biol 2007; 8:307-18.
15. Kooistra SM, Helin K. Molecular mechanisms and potential functions of histone demethylases. Nat Rev Mol Cell Biol 2012; 13:297-311.
16. Shi Y, Whetstine JR. Dynamic regulation of histone lysine methylation by demethylases. Mol Cell 2007; 25:1-14.
17. Suganuma T, Workman JL. Signals and combinatorial functions of histone modifications. Annu Rev Biochem 2011; 80:473-99.
18. Baek SH. When signaling kinases meet histones and histone modifiers in the nucleus. Mol Cell 2011; 42:274-84.
19. Suganuma T, Workman JL. MAP kinases and histone modification. J Mol Cell Biol 2012; 4:348-50.
20. Metzger E, Imhof A, Patel D et al. Phosphorylation of histone H3T6 by PKCβI controls demethylation at histone H3K4. Nature 2010; 464:792-6.
21. Sutcliffe EL, Bunting KL, He YQ et al. Chromatin-associated protein kinase C-θ regulates an inducible gene expression program and microRNAs in human T lymphocytes. Mol Cell 2011; 41:704-19.
22. Sutcliffe EL, Li J, Zafar A et al. Chromatinized protein kinase C-θ: can it escape the clutches of NF-κB? Front Immunol 2012; 3:260.
23. Clapier CR, Cairns BR. The biology of chromatin remodeling complexes. Annu Rev Biochem 2009; 78:273-304.
24. Mohrmann L, Verrijzer CP. Composition and functional specificity of SWI2/SNF2 class chromatin remodeling complexes. Biochim Biophys Acta 2005; 1681:59-73.
25. Bultman S, Gebuhr T, Yee D et al. A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol Cell 2000; 6:1287-95.
26. Reyes JC, Barra J, Muchardt C, Camus A, Babinet C, Yaniv M. Altered control of cellular proliferation in the absence of mammalian brahma (SNF2α). EMBO J 1998; 17:6979-91.
27. Trotter KW, Archer TK. The BRG1 transcriptional coregulator. Nucl Recept Signal 2008; 6:e004.
28. Shen W, Xu C, Huang W, Zhang J, Carlson JE, Tu X, Wu J, Shi Y. Solution structure of human Brg1 bromodomain and its specific binding to acetylated histone tails. Biochemistry 2007; 46:2100-10.
29. Bultman SJ, Gebuhr TC, Magnuson T. A Brg1 mutation that uncouples ATPase activity from chromatin remodeling reveals an essential role for SWI/SNF-related complexes in β-globin expression and erythroid development. Genes Dev 2005; 19:2849-61.
30. Griffin CT, Brennan J, Magnuson T. The chromatin-remodeling enzyme BRG1 plays an essential role in primitive erythropoiesis and vascular development. Development 2008; 135:493-500.
31. Gebuhr TC, Kovalev GI, Bultman S, Godfrey V, Su L, Magnuson T. The role of Brg1, a catalytic subunit of mammalian chromatin-remodeling complexes, in T cell development. J Exp Med 2003; 198:1937-49.
32. Wurster AL, Pazin MJ. BRG1-mediated chromatin remodeling regulates differentiation and gene expression of T helper cells. Mol Cell Biol 2008; 28:7274-85.
33. Zhang F, Boothby M. T helper type 1-specific Brg1 recruitment and remodeling of nucleosomes positioned at the IFN-γ promoter are Stat4 dependent. J Exp Med 2006; 203:1493-505.
34. Barski A, Cuddapah S, Cui K et al. High-resolution profiling of histone methylations in the human genome. Cell 2007; 129:823-37.
35. Roh TY, Cuddapah S, Cui K, Zhao K. The genomic landscape of histone modifications in human T cells. Proc Natl Acad Sci U S A 2006; 103:15782-7.
36. Roh TY, Cuddapah S, Zhao K. Active chromatin domains are defined by acetylation islands revealed by genome-wide mapping. Genes Dev 2005; 19:542-52.
37. Schones DE, Cui K, Cuddapah S, Roh TY, Barski A, Wang Z, Wei G, Zhao K. Dynamic regulation of nucleosome positioning in the human genome. Cell 2008; 132:887-98.
38. Wang Z, Zang C, Rosenfeld JA et al. Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 2008; 40:897-903.
39. Bernstein BE, Kamal M, Lindblad-Toh K et al. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 2005; 120:169-81.
40. Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA. A chromatin landmark and transcription initiation at most promoters in human cells. Cell 2007; 130:77-88.
41. Heintzman ND, Stuart RK, Hon G et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 2007; 39:311-8.
42. Koch CM, Andrews RM, Flicek P et al. The landscape of histone modifications across 1% of the human genome in five human cell lines. Genome Res 2007; 17:691-707.
43. Hon G, Wang W, Ren B. Discovery and annotation of functional chromatin signatures in the human genome. PLoS Comput Biol 2009; 5:e1000566.
44. Ernst J, Kellis M. Discovery and characterization of chromatin states for systematic annotation of the human genome. Nat Biotechnol 2010; 28:817-25.
45. Mikkelsen TS, Ku M, Jaffe DB et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 2007; 448:553-60.
46. Roh TY, Ngau WC, Cui K, Landsman D, Zhao K. High-resolution genome-wide mapping of histone modifications. Nat Biotechnol 2004; 22:1013-6.
47. + T cells. Immunity 2009; 30:912-25.
48. Lim PS, Hardy K, Bunting KL, Ma L, Peng K, Chen X, Shannon MF. Defining the chromatin signature of inducible genes in T cells. Genome Biol 2009; 10:R107.
49. Vakoc CR, Mandat SA, Olenchock BA, Blobel GA. Histone H3 lysine 9 methylation and HP1γ are associated with transcription elongation through mammalian chromatin. Mol Cell 2005; 19:381-91.
50. Bannister AJ, Zegerman P, Partridge JF, Miska EA, Thomas JO, Allshire RC, Kouzarides T. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 2001; 410:120-4.
51. Vakoc CR, Sachdeva MM, Wang H, Blobel GA. Profile of histone lysine methylation across transcribed mammalian chromatin. Mol Cell Biol 2006; 26:9185-95.
52. Cui K, Zang C, Roh TY, Schones DE, Childs RW, Peng W, Zhao K. Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell 2009; 4:80-93.
53. Zhao XD, Han X, Chew JL et al. Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells. Cell Stem Cell 2007; 1:286-98.
54. + T cells. Immunity 2009; 30:155-67.
55. Barski A, Jothi R, Cuddapah S, Cui K, Roh TY, Schones DE, Zhao K. Chromatin poises miRNA- and protein-coding genes for expression. Genome Res 2009; 19:1742-51.
56. Smith AE, Chronis C, Christodoulakis M et al. Epigenetics of human T cells during the G0→G1 transition. Genome Res 2009; 19:1325-37.
57. Diehn M, Alizadeh AA, Rando OJ, Liu CL, Stankunas K, Botstein D, Crabtree GR, Brown PO. Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation. Proc Natl Acad Sci U S A 2002; 99:11796-801.
58. Hargreaves DC, Horng T, Medzhitov R. Control of inducible gene expression by signal-dependent transcriptional elongation. Cell 2009; 138:129-45.
59. Wang Z, Zang C, Cui K, Schones DE, Barski A, Peng W, Zhao K. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell 2009; 138:1019-31.
60. Chen X, Wang J, Woltring D, Gerondakis S, Shannon MF. Histone dynamics on the interleukin-2 gene in response to T-cell activation. Mol Cell Biol 2005; 25:3209-19.
61. Kouskouti A, Talianidis I. Histone modifications defining active genes persist after transcriptional and mitotic inactivation. EMBO J 2005; 24:347-57.
62. H2 lymphocytes. Nat Immunol 2003; 4:78-86.
63. Northrop JK, Thomas RM, Wells AD, Shen H. Epigenetic remodeling of the IL-2 and IFN-γ loci in memory CD8 T cells is influenced by CD4 T cells. J Immunol 2006; 177:1062-9.
64. Cockerill PN, Shannon MF, Bert AG, Ryan GR, Vadas MA. The granulocyte-macrophage colony-stimulating factor/interleukin 3 locus is regulated by an inducible cyclosporin A-sensitive enhancer. Proc Natl Acad Sci U S A 1993; 90:2466-70.
65. Ward SB, Hernandez-Hoyos G, Chen F, Waterman M, Reeves R, Rothenberg EV. Chromatin remodeling of the interleukin-2 gene: distinct alterations in the proximal versus distal enhancer regions. Nucleic Acids Res 1998; 26:2923-34.
66. Rao S, Procko E, Shannon MF. Chromatin remodeling, measured by a novel real-time polymerase chain reaction assay, across the proximal promoter region of the IL-2 gene. J Immunol 2001; 167:4494-503.
67. Brettingham-Moore KH, Sprod OR, Chen X, Oakford P, Shannon MF, Holloway AF. Determinants of a transcriptionally competent environment at the GM-CSF promoter. Nucleic Acids Res 2008; 36:2639-53.
68. Schones DE, Zhao K. Genome-wide approaches to studying chromatin modifications. Nat Rev Genet 2008; 9:179-91.
69. Zhao K, Wang W, Rando OJ, Xue Y, Swiderek K, Kuo A, Crabtree GR. Rapid and phosphoinositol-dependent binding of the SWI/SNF-like BAF complex to chromatin after T lymphocyte receptor signaling. Cell 1998; 95:625-36.
70. De S, Wurster AL, Precht P, Wood WH 3rd, Becker KG, Pazin MJ. Dynamic BRG1 recruitment during T helper differentiation and activation reveals distal regulatory elements. Mol Cell Biol 2011; 31:1512-27.
71. Jin J, Cai Y, Li B, Conaway RC, Workman JL, Conaway JW, Kusch T. In and out: histone variant exchange in chromatin. Trends Biochem Sci 2005; 30:680-7.
72. Dawson MA, Kouzarides T, Huntly BJ. Targeting epigenetic readers in cancer. N Engl J Med 2012; 367:647-57.
73. Sutcliffe EL, Parish IA, He YQ et al. Dynamic histone variant exchange accompanies gene induction in T cells. Mol Cell Biol 2009; 29:1972-86.
74. Jin C, Felsenfeld G. Nucleosome stability mediated by histone variants H3.3 and H2A.Z. Genes Dev 2007; 21:1519-29.
75. Farris SD, Rubio ED, Moon JJ, Gombert WM, Nelson BH, Krumm A. Transcription-induced chromatin remodeling at the c-myc gene involves the local exchange of histone H2A.Z. J Biol Chem 2005; 280:25298-303.
76. Rao S, Gerondakis S, Woltring D, Shannon MF. c-Rel is required for chromatin remodeling across the IL-2 gene promoter. J Immunol 2003; 170:3724-31.
77. Attema JL, Reeves R, Murray V, Levichkin I, Temple MD, Tremethick DJ, Shannon MF. The human IL-2 gene promoter can assemble a positioned nucleosome that becomes remodeled upon T cell activation. J Immunol 2002; 169:2466-76.